A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis

被引：0
作者：
Satoshi Gando
Daizoh Saitoh
Hiroyasu Ishikura
Masashi Ueyama
Yasuhiro Otomo
Shigeto Oda
Shigeki Kushimoto
Katsuhisa Tanjoh
Toshihiko Mayumi
Toshiaki Ikeda
Toshiaki Iba
Yutaka Eguchi
Kohji Okamoto
Hiroshi Ogura
Kazuhide Koseki
Yuichiro Sakamoto
Yasuhiro Takayama
Kunihiro Shirai
Osamu Takasu
Yoshiaki Inoue
Kunihiro Mashiko
Takaya Tsubota
Shigeatsu Endo
机构：
[1] Hokkaido University Graduate School of Medicine,Division Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine
[2] National Defense Medical College,Division of Traumatology, National Defense Medical College Research Institute
[3] Fukuoka University,Department of Emergency and Critical Care Medicine
[4] Social Insurance Chukyo Hospital,Department of Traumatology, Critical Care Medicine and Burn Center
[5] Tokyo Medical and Dental University,Department of Acute Critical Care and Disaster Medicine
[6] Chiba University Graduate School of Medicine,Department of Emergency and Critical Care Medicine
[7] Tohoku University Graduate School of Medicine,Division of Emergency Medicine
[8] University School of Medicine,Division of Emergency and Critical Care Medicine, Department of Acute Medicine Nihon
[9] Nagoya University Graduate School of Medicine,Department of Emergency and Critical Care Medicine
[10] Tokyo Medical University Hachioji Medical Center,Department of Critical Care and Emergency Medicine
[11] Juntendo University,Department of Emergency Medicine
[12] Seta Tsukinowa-cho,Critical and Intensive Care Medicine, Shiga University of Medical Science
[13] University of Occupational and Environmental Health,Department of Surgery 1, School of Medicine
[14] Osaka University Medical School,Department of Traumatology and Acute Critical Care Medicine
[15] Kawaguchi Municipal Medical Center,Emergency and Critical Care Medicine
[16] Saga University,Department of Emergency and Critical Care Medicine, Faculty of Medicine
[17] Gifu University,Department of Emergency and Disaster Medicine, Advanced Critical Care Center
[18] Kurume University School of Medicine,Department of Emergency and Critical Care Medicine
[19] Juntendo University Urayasu Hospital,Department of Emergency and Critical Care Medicine
[20] Nippon Medical School,Shock and Trauma Center, Chiba
[21] Toho University Omori Medical Center,Hokusoh Hospital
[22] Iwate Medical University,Emergency and Critical Care Center
来源：
Critical Care | / 17卷
关键词：
Severe Sepsis; Sequential Organ Failure Assessment; Antithrombin; Disseminate Intravascular Coagulation; Sequential Organ Failure Assessment Score;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 247 条
  • [1] Wiedermann CJ(2006)Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis Crit Care 10 209-S37
  • [2] Opal SM(2000)Therapeutic rationale for antithrombin III in sepsis Crit Care Med 28 S34-S43
  • [3] Fourrier F(2000)Clinical trial results with antithrombin III in sepsis Crit Care Med 28 S38-888
  • [4] Jourdain M(1993)Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intra vascular coagulation Chest 104 882-672
  • [5] Tournoys A(1998)Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis Intensive Care Med 24 663-342
  • [6] Fourrier F(1998)Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study Intensive Care Med 24 336-1878
  • [7] Chopin C(2001)High-dose antithrombin III in severe sepsis. A randomized controlled trial JAMA 286 1869-124
  • [8] Huart JJ(2001)Success or failure in phase III sepsis trials: comparisons between the Drotorecogin alfa (activated) and antithrombin III clinical trials Advance in Sepsis 1 114-856
  • [9] Runge I(2006)Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin Thromb Haemost 95 850-292
  • [10] Caron C(2006)High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety Crit Care Med 34 285-1638
12345678910